share_log

Ultragenyx Pharmaceutical(RARE.US) Director Sells US$23,932.32 in Common Stock

Moomoo News ·  Jul 3 14:49

$Ultragenyx Pharmaceutical (RARE.US)$ Director Sanders Corazon (Corsee) D. sold 584 shares of common stock on Jul 2, 2024 at an average price of $40.98 for a total value of $23,932.32.

1720032558940036579.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment